Brown-Forman Corporation Class B vs Inovio Pharmaceuticals Inc — how do they compare? Brown-Forman Corporation Class B trades at $29.9, while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: Brown-Forman Corporation Class B is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| BF.B | INO | |
|---|---|---|
Sector | Consumer Staples | Health |
52-Week High | $31.26 | $2.87 |
52-Week Low | $22.80 | $0.66 |
Market Cap | — | $78.55M |
Enterprise Value | — | $49.56M |
Trailing returns across standard periods
Brown-Forman is the largest U.S.-domiciled producer of distilled spirits. The firm reports only a single operating segment, and whiskey represents its primary business driver, generating roughly three-quarters of sales, undergirded by the Jack Daniel's brand as well as bourbons such as Woodford Reserve and Old Forrester. Notable nonwhiskey offerings include tequilas such as el Jimador and Herradura. The firm operates globally, with products sold in more than 170 countries, and adapts its route-to-consumer model depending on regulation as well as the prevailing competitive dynamics in a given market. For example, it sells through distributors in the U.S. but operates its own logistics apparatus in many other countries. The company remains under the control of the Brown family.
Read more on BF.B →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →